Christopher D Watt, MD, PhD
Christopher D Watt, MD, PhD
Assistant Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Contact information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Education:
B.S. (Biology)
University of Kentucky, 1996.
Ph.D. (Cell and Molecular Biology)
University of Pennsylvania School of Medicine, 2003.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 2005.
Permanent linkB.S. (Biology)
University of Kentucky, 1996.
Ph.D. (Cell and Molecular Biology)
University of Pennsylvania School of Medicine, 2003.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 2005.
Description of Clinical Expertise
Molecular PathologySelected Publications
Frank R, Baloch ZW, Gentile C, Watt CD, LiVolsi VA: Multifocal fibrosing thyroiditis and its association with papillary thyroid carcinoma using BRAF pyrosequencing. Modern Pathology 26(S2), Feb 2013 Notes: United States and Canadian Academy of Pathology 102nd Annual Meeting (abstract 548).Nybakken G, Watt CD, Morrissette JD, Bagg A, Carroll M, Perl AE: Diverse histopathologic and molecular responses of acute myeloid leukemia to the FLT3 inhibitor quizartinib (AC220). Blood 120(21), Nov 2012 Notes: 2012 Annual Meeting of the American Society of Hematology (Abstract 885).
Sohal D, Teitelbaum U, Uehara T, Mykulowycz K, Watt CD, Damjanov N, Giantonio B, Carberry M, Wissel P, Jacobs-Small M, O'Dwyer P, Sun W, Sepulveda AR.: Mutational analysis of EGFR, KRAS and BRAF in advanced cholangiocarcinoma and association with clinical outcomes – an interim report of a phase II trial. The Journal of Molecular Diagnostics Oct 2012 Notes: Association for Molecular Pathology 2012 Annual Meeting on Genomic Medicine Abstract.
Gentile C, Segal J, Van Deerlin VM, Watt CD: A comparative study of methods for extracting genomic DNA from FFPE tissue samples. The Journal of Molecular Diagnostics Oct 2012 Notes: Association for Molecular Pathology 2012 Annual Meeting on Genomic Medicine Abstract.
Shah M, Glaser LG, Thornberg A, Rusterholz K, Watt CD, Van Deerlin VM : Comparative study between three different methodologies for HCV genotyping. The Journal of Molecular Diagnostics Oct 2012 Notes: Association for Molecular Pathology 2012 Annual Meeting on Genomic Medicine Abstract.
Behling KC, Letrero RJ, Gonzalez JR, Nathanson KL, Van Deerlin VM, Watt CD: Use of MassARRAY technology for determination of mutation status in multiple clinically relevant genes in malignant melanoma. The Journal of Molecular Diagnostics Oct 2012 Notes: Association for Molecular Pathology 2012 Annual Meeting on Genomic Medicine Abstract.
Sohal D, Teitelbaum UR, Uehara T, Mykulowycz K, Watt CD, Damjanov N, Giantonio BJ, Carberry M, Wissel PS, Jacobs-Small M, O'Dwyer PJ, Sepulveda A and Sun W: A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma, with correlative analysis of EGFR, KRAS and BRAF: An interim report. Journal of Clinical Oncology 30(15), May 2012 Notes: 2012 ASCO Annual Meeting Proceedings (abstract 4111)
Gopal PP, Watt CD, Aikawa V, Vachani A, Rengan R, Kucharczuk J, Langer C, Albelda S, Van Deerlin V, Morrissette J, Feldman M, Litzky LA, Deshpande CG: Morphologic and molecular features of primary lung adenocarcinomas that metastasize to brain. Modern Pathology 25(S2), Feb 2012 Notes: United States and Canadian Academy of Pathology 101st Annual Meeting (abstract 1987).
Reddy P, Choppa P, Jamehdor MR, Moradian MM, Potter NT, Quigley MM, Watt CD, Campbell SA, Wong WW, Höfling HA, Manning BM, Mignault AA, Ossa DF, Stein DF, Stiegler P, Wang S, Yang F, Wetzler M: Inter- and intra-laboratory variability among BCR-ABL1 monitoring tests and impact of PCR platform standardization: from the REVEAL BCR-ABL1 methods comparison study. 14th International CML Conference 2012 Notes: ESH-iCML International Conference, 2012.
Reddy P, Choppa P, Moradian M, Potter N, Quigley M, Watt CD, Höfling H, Manning B, Mignault A, Mullaney B, Ossa D, Stein A, Wang S, Yang F, Wetzler M: Evaluation of MMR concordance based on either international scale or national comprehensive cancer network criteria using reconstructed “virtual” CML patient profiles from the REVEAL BCR-ABL methods comparison study. Blood 118(21), Dec 2011 Notes: 2011 Annual Meeting of the American Society of Hematology (abstract 3542).